Employees talking

资讯

Resource Types

Events

公司新闻

01

2月 28, 2022

The Importance of Correctly Diagnosing Immunocompromised Individuals and the Role of T Cells in Diagnostics
02

6月 10, 2021

Oxford Immunotec Presents Data on the Use of T-SPOT®.TB Test in Children over the Age of 2 to The Korean Society of Pediatric Infectious Diseases
03

11月 10, 2020

Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 is Published by PHE and Oxford Immunotec
04

9月 29, 2020

Oxford Immunotec Announces Food and Drug Administration (FDA) Clearance of the T-SPOT®.TB Test for Use in Pediatrics Over the Age of Two
05

9月 22, 2020

Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test
06

7月 20, 2020

Oxford Immunotec Announces Agreement with Stop TB Partnership – Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries
07

5月 19, 2020

Oxford Immunotec releases the T-SPOT® 𝘋𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺™ SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2
08

5月 5, 2020

Oxford Immunotec Reports First Quarter 2020 Financial Results
09

4月 29, 2020

Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020
10

4月 21, 2020

Oxford Immunotec announces successful re-registration of the T-SPOT®.TB test in China
11

3月 2, 2020

Oxford Immunotec Reports Fourth Quarter and Full Year 2019 Financial Results
12

2月 27, 2020

Oxford Immunotec to Present at the Cowen and Company 40th Annual Health Care Conference
13

2月 24, 2020

Oxford Immunotec Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 2, 2020
14

2月 20, 2020

Oxford Immunotec Announces New Data on the Utility of T-SPOT®.CMV in Kidney and Stem Cell Transplant
15

1月 23, 2020

Oxford Immunotec Announces Donation in Support of Coronavirus Testing Efforts to Help Differentiate Tuberculosis from the COVID-19
最新资讯